Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedFallopian tube cancer was added to the conditions list, and the page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedA glossary display option was added, and page metadata was updated to include 'Last Update Submitted that Met QC Criteria,' 'No FEAR Act Data,' and revision note v3.4.0.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedA consolidated Locations section lists study sites across Florida, Illinois, Maryland, Massachusetts, Missouri, New York, Pennsylvania, Tennessee, and Virginia. The page updates to revision v3.3.3 by replacing the previous state-specific location subsections from v3.3.2.SummaryDifference0.9%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.